Home/Alex Hope

What Are The Hot Investment Areas? – Panel Discussion (Anglonordic Life Science Conference)

Last month, Amber Tong, Senior Editor at Endpoints, chaired a panel of Europe's leading VC investors during the Anglonordic life science conference where they were asked 'What Are The Hot Investment Areas?' Amber was joined by a fantastic panel consisting of Hakan Goker, Deborah Harland, Nanna Lüneborg, and Stephan Christgau. The discussion was extremely captivating, the investors spoke about a range of things including how the pandemic has impacted their business, the essential components to building a successful biotech, and the current hot markets for investment. Watch the panel discussion again here.

By |30 June 2021|Categories: News|0 Comments

Nazneen Rahman – BioLeader Interview

Nazneen Rahman BioLeader Interview - Dr Nazneen Rahman, Founder & CEO YewMaker, NED AstraZeneca (June 2021) Nazneen Rahman CBE, MD, PhD, FRCP, FMedSci Nazneen Rahman has made significant contributions to science and medical research over the last 25 years. She is an internationally recognised expert in cancer genomics and was Professor of Human Genetics at the Institute of Cancer Research and Head of Cancer Genetics at the Royal Marsden Hospital, London until 2018. Nazneen is a Non-Executive Director at AstraZeneca, Chair of the AstraZeneca Science Committee and oversees Sustainability for the Board. Nazneen is now focussed on making healthcare [...]

By |23 June 2021|Categories: BioLeaders|0 Comments

Kate Bingham – Keynote Speaker (Anglonordic Life Science Conference)

In May 2020 Kate Bingham was appointed Chair of the UK Vaccine Taskforce, reporting to the Prime Minister to lead UK efforts to find and manufacture a COVID-19 vaccine. This was a six month engagement which Kate stepped down from in December 2020. On December 8th 2020 the UK kicked off its vaccination programme, the first Western country to do so. In recognition of the world-beating and extraordinary success of the UK’s vaccination programme, Kate has been included on the Queen’s Birthday Honours List and awarded a well deserved damehood for her services to the procurement, manufacture and distribution [...]

By |16 June 2021|Categories: News|0 Comments

Building Your Board – PIR International Panel Discussion (Anglonordic Life Science Conference)

PIR International recently hosted a panel of Biotech industry experts on the topic of ‘Building your Board’ during the 17th Anglonordic life science conference, doing a deep dive on all things necessary to set-up a successful Board for all stages of growth. As anticipated, it was expertly hosted by Maureen Coleman. Maureen was joined by a superb panel of Eva-Lotta Allen, Edwin Moses, Patrick Vink and Melanie Lee. The discussion was tremendously insightful, providing healthy debate and conversation around all aspects of Board composition, diversity, structure, culture and much more. The utilisation of independent board members, why and when [...]

By |09 June 2021|Categories: News|0 Comments

Peter Joyce – BioLeader Interview

Peter Joyce BioLeader Interview - Peter Joyce (April 2021) Peter Joyce is Co-founder and Chief Executive Officer of Grey Wolf, having founded the Company in 2017 with Tom McCarthy. Prior to Grey Wolf Peter was at Vertex Pharmaceuticals where he led drug discovery projects, had responsibility for leading a number of target identification teams that led to multiple novel drug discovery projects and was involved in delivering clinical drug candidates. Peter has a broad scientific experience across therapeutic areas having worked on projects in oncology, genetic diseases and neurodegeneration. He also pioneered the development of complex neurological assays suitable [...]

By |21 April 2021|Categories: BioLeaders|0 Comments

Eric Mayes – BioLeader Interview

Eric Mayes BioLeader Interview - Eric Mayes (April 2021) Dr Eric Mayes is CEO of Endomag and has over 20 years’ experience in developing and leading materials technology companies spanning data storage, display technology, printed electronics and medical devices. Eric has led oncology-focused Endomag through its rapid growth since marketing its first device for staging breast cancer in late 2012. The company has now helped over 130,000 patients receive a higher standard of care in over 550 hospitals across 43 countries. Prior to joining Endomag in 2010, Eric served as Director of Commercial Development for Cambridge Display Technology (CDT) [...]

By |20 April 2021|Categories: BioLeaders|0 Comments

IR35 6th April 2021 – What You Need to Know

The changes to IR35 legislation are fast approaching, coming into effect in the UK private sector, which includes the Biotech and Life Science industry, at the start of the new tax year on the 6th April 2021. These changes are designed to collect Income Tax and National Insurance and reduce tax avoidance by contractors, who are believed to be “disguised employees”. Those affected by the changes to IR35 are: Workers who provide their services through an intermediary. Businesses who receive services from a worker through an intermediary. Agencies providing workers’ services as an intermediary. The UK Biotech and Life [...]

By |01 April 2021|Categories: News|0 Comments

Huw Jones – BioLeader Interview

Huw Jones BioLeader Interview - Huw Jones (March 2021) For over 20 years, Huw Jones has been a serial CEO and NED of early stage and listed biotech companies. Throughout his varied career he has launched dozens of new medicines, in several countries, completed tens of M&A transactions and managed many drug development programmes. He was appointed CEO of Evgen Pharma PLC, in October 2020, an AIM listed, clinical stage cancer and inflammation company. He recently led the raise of £10m in a placing and up to a further £1m in an open offer in a heavily oversubscribed and [...]

By |17 March 2021|Categories: BioLeaders|0 Comments
Go to Top